AAPL340.86-2.08 (-0.61%) ▼|ABBV289.30+6.62 (+2.34%) ▲|ABT103.44-0.62 (-0.60%) ▼|ACN240.67+3.74 (+1.58%) ▲|ADBE255.12+8.03 (+3.25%) ▲|AMAT405.22-7.89 (-1.91%) ▼|AMD542.38+4.33 (+0.80%) ▲|AMGN433.87+8.93 (+2.10%) ▲|AMT185.39+2.36 (+1.29%) ▲|AMZN263.08+0.63 (+0.24%) ▲|AVGO335.10+0.51 (+0.15%) ▲|AXP320.55+4.14 (+1.31%) ▲|BA189.91-1.51 (-0.79%) ▼|BAC51.03+0.64 (+1.26%) ▲|BKNG163.27+0.67 (+0.41%) ▲|BLK1,135.97+11.37 (+1.01%) ▲|BMY61.36+2.53 (+4.29%) ▲|BNY144.20+1.76 (+1.24%) ▲|BRK-B538.54+6.31 (+1.18%) ▲|C122.41+0.72 (+0.59%) ▲|CAT725.81+0.02 (+0.00%) ▲|CL94.06+1.20 (+1.29%) ▲|CMCSA22.12+0.22 (+1.00%) ▲|COF201.61+1.78 (+0.89%) ▲|COP144.94-0.30 (-0.21%) ▼|COST994.24-1.30 (-0.13%) ▼|CRM239.41-3.05 (-1.26%) ▼|CSCO106.13-0.37 (-0.35%) ▼|CVS94.59+1.91 (+2.06%) ▲|CVX223.53-0.85 (-0.38%) ▼|DE635.15+8.15 (+1.30%) ▲|DHR226.43+2.00 (+0.89%) ▲|DIS111.26+1.67 (+1.52%) ▲|DUK121.12+1.85 (+1.55%) ▲|EMR159.67-0.87 (-0.54%) ▼|FDX300.27+6.49 (+2.21%) ▲|GD343.00+1.57 (+0.46%) ▲|GE297.45-13.84 (-4.44%) ▼|GEV899.53-8.91 (-0.98%) ▼|GILD155.41+2.34 (+1.53%) ▲|GM76.69-6.06 (-7.32%) ▼|GOOG337.70-2.46 (-0.72%) ▼|GOOGL341.56-2.62 (-0.76%) ▼|GS885.62+9.84 (+1.12%) ▲|HD315.71+5.83 (+1.88%) ▲|HON212.83+2.85 (+1.36%) ▲|IBM240.07+3.68 (+1.56%) ▲|INTC93.26+1.23 (+1.33%) ▲|INTU335.41+9.79 (+3.01%) ▲|ISRG436.38+3.20 (+0.74%) ▲|JNJ259.09+5.30 (+2.09%) ▲|JPM336.37+2.84 (+0.85%) ▲|KO92.97-0.45 (-0.48%) ▼|LIN498.89-4.55 (-0.90%) ▼|LLY1,296.20+55.86 (+4.50%) ▲|LMT547.25-0.98 (-0.18%) ▼|LOW198.90+2.98 (+1.52%) ▲|LRCX265.19-7.01 (-2.58%) ▼|MA622.14+5.74 (+0.93%) ▲|MCD246.17+3.50 (+1.44%) ▲|MDLZ63.91+0.57 (+0.90%) ▲|MDT94.29+1.52 (+1.64%) ▲|META690.30-15.14 (-2.15%) ▼|MMM170.09+8.08 (+4.99%) ▲|MO74.99+0.90 (+1.21%) ▲|MRK148.25+4.62 (+3.21%) ▲|MS180.62+2.15 (+1.20%) ▲|MSFT531.69-1.83 (-0.34%) ▼|MU911.34+6.44 (+0.71%) ▲|NEE79.10+0.93 (+1.18%) ▲|NFLX69.71-0.15 (-0.21%) ▼|NKE37.78+0.57 (+1.53%) ▲|NOW148.42+3.06 (+2.11%) ▲|NVDA217.03-0.06 (-0.03%) ▼|ORCL132.33+2.74 (+2.11%) ▲|PEP134.05+0.48 (+0.36%) ▲|PFE30.13+0.69 (+2.34%) ▲|PG158.51+0.82 (+0.52%) ▲|PLTR194.61+0.46 (+0.24%) ▲|PM201.31+0.26 (+0.13%) ▲|QCOM175.35+1.82 (+1.05%) ▲|RTX190.27-1.84 (-0.96%) ▼|SBUX99.54+1.67 (+1.71%) ▲|SCHW90.78+1.20 (+1.34%) ▲|SO90.75+1.48 (+1.66%) ▲|SPG205.75+3.26 (+1.61%) ▲|T23.51+0.31 (+1.31%) ▲|TMO687.69+8.31 (+1.22%) ▲|TMUS158.51+2.42 (+1.55%) ▲|TSLA373.79+5.73 (+1.56%) ▲|TXN279.73+3.58 (+1.30%) ▲|UBER68.69-1.27 (-1.82%) ▼|UNH421.26+14.38 (+3.53%) ▲|UNP287.20+0.19 (+0.06%) ▲|UPS98.73+1.27 (+1.30%) ▲|USB58.83+0.98 (+1.69%) ▲|V407.05+4.13 (+1.03%) ▲|VZ44.52+0.37 (+0.84%) ▲|WFC81.91+0.11 (+0.13%) ▲|WMT118.18-0.52 (-0.44%) ▼|XOM176.57-1.71 (-0.96%) ▼|AAPL340.86-2.08 (-0.61%) ▼|ABBV289.30+6.62 (+2.34%) ▲|ABT103.44-0.62 (-0.60%) ▼|ACN240.67+3.74 (+1.58%) ▲|ADBE255.12+8.03 (+3.25%) ▲|AMAT405.22-7.89 (-1.91%) ▼|AMD542.38+4.33 (+0.80%) ▲|AMGN433.87+8.93 (+2.10%) ▲|AMT185.39+2.36 (+1.29%) ▲|AMZN263.08+0.63 (+0.24%) ▲|AVGO335.10+0.51 (+0.15%) ▲|AXP320.55+4.14 (+1.31%) ▲|BA189.91-1.51 (-0.79%) ▼|BAC51.03+0.64 (+1.26%) ▲|BKNG163.27+0.67 (+0.41%) ▲|BLK1,135.97+11.37 (+1.01%) ▲|BMY61.36+2.53 (+4.29%) ▲|BNY144.20+1.76 (+1.24%) ▲|BRK-B538.54+6.31 (+1.18%) ▲|C122.41+0.72 (+0.59%) ▲|CAT725.81+0.02 (+0.00%) ▲|CL94.06+1.20 (+1.29%) ▲|CMCSA22.12+0.22 (+1.00%) ▲|COF201.61+1.78 (+0.89%) ▲|COP144.94-0.30 (-0.21%) ▼|COST994.24-1.30 (-0.13%) ▼|CRM239.41-3.05 (-1.26%) ▼|CSCO106.13-0.37 (-0.35%) ▼|CVS94.59+1.91 (+2.06%) ▲|CVX223.53-0.85 (-0.38%) ▼|DE635.15+8.15 (+1.30%) ▲|DHR226.43+2.00 (+0.89%) ▲|DIS111.26+1.67 (+1.52%) ▲|DUK121.12+1.85 (+1.55%) ▲|EMR159.67-0.87 (-0.54%) ▼|FDX300.27+6.49 (+2.21%) ▲|GD343.00+1.57 (+0.46%) ▲|GE297.45-13.84 (-4.44%) ▼|GEV899.53-8.91 (-0.98%) ▼|GILD155.41+2.34 (+1.53%) ▲|GM76.69-6.06 (-7.32%) ▼|GOOG337.70-2.46 (-0.72%) ▼|GOOGL341.56-2.62 (-0.76%) ▼|GS885.62+9.84 (+1.12%) ▲|HD315.71+5.83 (+1.88%) ▲|HON212.83+2.85 (+1.36%) ▲|IBM240.07+3.68 (+1.56%) ▲|INTC93.26+1.23 (+1.33%) ▲|INTU335.41+9.79 (+3.01%) ▲|ISRG436.38+3.20 (+0.74%) ▲|JNJ259.09+5.30 (+2.09%) ▲|JPM336.37+2.84 (+0.85%) ▲|KO92.97-0.45 (-0.48%) ▼|LIN498.89-4.55 (-0.90%) ▼|LLY1,296.20+55.86 (+4.50%) ▲|LMT547.25-0.98 (-0.18%) ▼|LOW198.90+2.98 (+1.52%) ▲|LRCX265.19-7.01 (-2.58%) ▼|MA622.14+5.74 (+0.93%) ▲|MCD246.17+3.50 (+1.44%) ▲|MDLZ63.91+0.57 (+0.90%) ▲|MDT94.29+1.52 (+1.64%) ▲|META690.30-15.14 (-2.15%) ▼|MMM170.09+8.08 (+4.99%) ▲|MO74.99+0.90 (+1.21%) ▲|MRK148.25+4.62 (+3.21%) ▲|MS180.62+2.15 (+1.20%) ▲|MSFT531.69-1.83 (-0.34%) ▼|MU911.34+6.44 (+0.71%) ▲|NEE79.10+0.93 (+1.18%) ▲|NFLX69.71-0.15 (-0.21%) ▼|NKE37.78+0.57 (+1.53%) ▲|NOW148.42+3.06 (+2.11%) ▲|NVDA217.03-0.06 (-0.03%) ▼|ORCL132.33+2.74 (+2.11%) ▲|PEP134.05+0.48 (+0.36%) ▲|PFE30.13+0.69 (+2.34%) ▲|PG158.51+0.82 (+0.52%) ▲|PLTR194.61+0.46 (+0.24%) ▲|PM201.31+0.26 (+0.13%) ▲|QCOM175.35+1.82 (+1.05%) ▲|RTX190.27-1.84 (-0.96%) ▼|SBUX99.54+1.67 (+1.71%) ▲|SCHW90.78+1.20 (+1.34%) ▲|SO90.75+1.48 (+1.66%) ▲|SPG205.75+3.26 (+1.61%) ▲|T23.51+0.31 (+1.31%) ▲|TMO687.69+8.31 (+1.22%) ▲|TMUS158.51+2.42 (+1.55%) ▲|TSLA373.79+5.73 (+1.56%) ▲|TXN279.73+3.58 (+1.30%) ▲|UBER68.69-1.27 (-1.82%) ▼|UNH421.26+14.38 (+3.53%) ▲|UNP287.20+0.19 (+0.06%) ▲|UPS98.73+1.27 (+1.30%) ▲|USB58.83+0.98 (+1.69%) ▲|V407.05+4.13 (+1.03%) ▲|VZ44.52+0.37 (+0.84%) ▲|WFC81.91+0.11 (+0.13%) ▲|WMT118.18-0.52 (-0.44%) ▼|XOM176.57-1.71 (-0.96%) ▼|
17.9 C
New York
Tuesday, October 20, 2026

Tag: expansion

Saudi Arabia Generic Drugs Market Outlook Report 2025-2033 | Government Cost-Cutting, Local Manufacturing, and Public Awareness Fuel Rapid Growth

The Saudi Arabia Generic Drugs Market is projected to expand from US$ 4.05 billion in 2024 to US$ 8.11 billion by 2033, registering a CAGR of 8.02%. This growth is driven by increased healthcare needs, government initiatives to reduce pharmaceutical spending, and rising awareness of affordable alternatives. Supportive regulatory policies by the Saudi Food and Drug Authority (SFDA) and investments in local manufacturing are further spurring market expansion. The market is also bolstered by growing demand due to the rising prevalence of chronic diseases and increased acceptance among consumers and healthcare professionals.
The Saudi Arabia Generic Drugs Market is projected to expand from US$ 4.05 billion in 2024 to US$ 8.11 billion by 2033, registering a CAGR of 8.02%. This growth is driven by increased healthcare needs, government initiatives to reduce pharmaceutical spending, and rising awareness of affordable alternatives. Supportive regulatory policies by the Saudi Food and Drug Authority (SFDA) and investments in local manufacturing are further spurring market expansion. The market is also bolstered by growing demand due to the rising prevalence of chronic diseases and increased acceptance among consumers and healthcare professionals.

Oil & Gas Market Size to Surpass USD 8.79 Trillion by 2034

According to Towards Chemical and Materials, the global Oil & Gas market size was estimated at USD 6.10 Trillion in 2024 and is expected to surpass around USD 8.79 Trillion by 2034, growing at a compound annual growth rate (CAGR) of 3.72% over the forecast period from 2025 to 2034.
According to Towards Chemical and Materials, the global Oil & Gas market size was estimated at USD 6.10 Trillion in 2024 and is expected to surpass around USD 8.79 Trillion by 2034, growing at a compound annual growth rate (CAGR) of 3.72% over the forecast period from 2025 to 2034.

Ankura Launches Turnaround & Restructuring Practice in Germany

Led by Senior Managing Director Jens Nawrath, the new practice enhances global T&R capabilities FRANKFURT, Germany, Aug. 14, 2025 /PRNewswire/ -- Ankura Consulting Group,...

SM Investments H1 net income rises 6% to PHP42.6 billion

PASAY CITY, Philippines, Aug. 14, 2025 /PRNewswire/ -- SM Investments Corporation (SM Investments) posted a consolidated net income of PHP42.6 billion in the first...

SM Investments H1 net income rises 6% to PHP42.6 billion

PASAY CITY, Philippines, Aug. 14, 2025 /PRNewswire/ -- SM Investments Corporation (SM Investments) posted a consolidated net income of PHP42.6 billion in the first...

FRONTERA ANNOUNCES SECOND QUARTER 2025 RESULTS

Recorded $455.2 million in Net Loss Mainly due to Non-Cash Impairment Charges Related to its Interest in the Corentyne License and Ecuadorian Assets Increased Total...

FRONTERA ANNOUNCES SECOND QUARTER 2025 RESULTS

Recorded $455.2 million in Net Loss Mainly due to Non-Cash Impairment Charges Related to its Interest in the Corentyne License and Ecuadorian Assets Increased Total...

Centrus Announces Pricing of Oversubscribed and Upsized Private Offering of Zero-Coupon Convertible Senior Notes Due 2032

BETHESDA, Md. , Aug. 13, 2025 /PRNewswire/ -- Centrus Energy Corp. (NYSE American: LEU) ("Centrus") today announced the pricing of $700 million aggregate principal amount of...

Felicity Expands Global Footprint with Singapore Office

Invests $1 Million To Build A Strategic Team Globally To Accelerate Growth BANGALORE, India, Aug. 14, 2025 /PRNewswire/ -- Felicity, an AI enabled game-tech company known...

Coupa Launches Virtual Cards in Japan to Modernize B2B Payments

Coupa Pay Virtual Cards seamlessly integrate into payment workflows powered by AI-driven insights for visibility and control TOKYO, Aug. 14, 2025 /PRNewswire/ -- Coupa,...

Felicity Expands Global Footprint with Singapore Office

Invests $1 Million To Build A Strategic Team Globally To Accelerate Growth BANGALORE, India, Aug. 14, 2025 /PRNewswire/ -- Felicity, an AI enabled game-tech company known...

Neuro Sharp Gains Recognition in 2025 as Your Ultimate Brain Enhancement Formula

Scientifically Formulated Nootropic Backed by 2025 Research for Sharper Focus and Cognitive Support
Scientifically Formulated Nootropic Backed by 2025 Research for Sharper Focus and Cognitive Support

Condor Announces 2025 Second Quarter Results and USD $5.0 Million Bridge Loan

CALGARY, Alberta, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based, internationally focused energy transition company focused on Central Asia is pleased to announce the release of its unaudited interim condensed consolidated financial statements for the three and six months ended June 30, 2025 (the “Financial Statements”), together with the related management’s discussion and analysis. These documents will be made available under Condor’s profile on SEDAR+ at www.sedarplus.ca and on the Condor website at www.condorenergies.ca. Readers are invited to review the latest corporate presentation available on the Condor website. All financial amounts in this news release are presented in Canadian dollars, unless otherwise stated.

AlphaCur Gains Momentum in 2025 as a Leading Formula for Neuropathy Nerve Health Support

AlphaCur Introduces Ingredient-First Nerve Health Formula as Interest in Neuropathy Support and Long-Term Wellness Grows in 2025
AlphaCur Introduces Ingredient-First Nerve Health Formula as Interest in Neuropathy Support and Long-Term Wellness Grows in 2025

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsExpansion